z-logo
open-access-imgOpen Access
Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants
Author(s) -
Jeffrey F. Scott,
Kevin Brough,
Konstantin V. Grigoryan,
John G. Muzic,
Grace Y. Kim,
Rosalynn R.Z. Conic,
Sheena T. Hill,
Jerry D. Brewer,
Christian L. Baum,
Mark R. Litzow,
William J. Hogan,
Mrinal M. Patnaik,
Shahrukh K. Hashmi,
Hillard M. Lazarus,
Jeremy S. Bordeaux,
Cheryl L. Thompson,
Meg R. Gerstenblith,
Julia S. Lehman
Publication year - 2020
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2020.0559
Subject(s) - medicine , hematopoietic cell , haematopoiesis , hematopoietic stem cell , keratinocyte growth factor , immunology , carcinoma , oncology , stem cell , cancer research , genetics , growth factor , receptor , biology
This study found validated independent risk factors for keratinocyte carcinoma after alloHCT that are enriched with host- compared with transplant-associated risk factors. These findings highlight the importance of assessing host-associated risk factors for keratinocyte carcinoma in patients eligible for alloHCT. Future studies should examine whether keratinocyte carcinoma risk stratification before alloHCT may inform long-term surveillance strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom